Put CAEH On Your Radar Now
Caleco Pharma (OTCBB: CAEH) is focused on the ongoing research and development of its pipeline of over-the-counter and prescription medications including its proprietary antiviral and "Liver Health" OTC formulations. In addition Caleco Pharma is developing Dermatological Products based on the active ingredients found in its proprietary formulation. To date, Caleco Pharma's intellectual property covering the Liver Health formulations and derivatives consists of patent applications in the United States, Europe and Canada and four European Drug Master File applications.
Caleco Pharma (OTCBB: CAEH) is pursuing a two-tiered strategy to bring the parent herbal formulation to market while continuing development of CPC.12115HP201 and CPC.12115HP202.Caleco Pharma is actively engaged in pre-commercialization projects related to bringing the proprietary "Liver Health" formulation to worldwide markets as an oral health supplement following additional clinical trials expected to start in the first half of 2010. In addition, derivatives of the parent herbal formulation are being considered for oral supplement development targeted at immune system enhancement and as dermatologic products for use in common chronic dermatologic conditions.
To date, the Company's intellectual property covering the "Liver Health" formulations is comprised of patent applications in the United States, Europe and Canada and four European Drug Master File applications
Additional information is available on the company's website at: http://www.calecopharmacorp.com/
No comments:
Post a Comment